PHQ-9 Question 9 and Suicidal Ideation: Clinical and Legal Responsibilities for Outpatient Clinics

PHQ-9 suicidal ideation outpatient clinics is the clinical and operational responsibility that arises when a patient responds affirmatively to the ninth item of the Patient Health Questionnaire-9, which asks: over the last two weeks, how often have you been bothered by thoughts that you would be better off dead or of hurting yourself in some way? For outpatient clinics, a non-zero response to Question 9 is not a diagnosis of suicidal intent. It is a clinical flag that requires an immediate, documented response before the patient reaches the clinician. What that response looks like, who is responsible for it, and what the clinical and legal consequences of missing it are, is what this guide covers.

Key Takeaways

1. Question 9 Is a Clinical Flag, Not a Standalone Risk Assessment: A non-zero score on PHQ-9 Question 9 indicates the patient has experienced thoughts of self-harm or death in the past two weeks. It is not a confirmed diagnosis of suicidal intent. It is a flag that requires further clinical evaluation before the consultation begins.
2. Omitting Question 9 Is Clinically and Ethically Indefensible: A STAT News investigation published in August 2025 found that some healthcare organisations are sending out PHQ-8 forms with Question 9 removed due to liability concerns. The article describes this practice as not only morally indefensible but also unsupported by any evidence and likely born out of stigma regarding mental illness.
3. The Timing of Clinical Response Is the Core Responsibility: The clinical and legal responsibility attached to a positive Question 9 response is not simply that the clinic must respond. It is that the clinic must respond before the patient reaches the clinician. A flag discovered mid-session leaves no preparation time.
4. Automated AI PHQ-9 Screening Closes the Response Gap: When Question 9 is endorsed during a pre-visit voice-guided screening, an immediate alert reaches clinical staff before the patient enters the building. This is the only workflow that consistently guarantees the flag reaches the right person before the session begins.
5. Documentation of the Response Is a Legal Requirement, Not Optional: The clinical response to a positive Question 9 must be documented in the patient record. An undocumented response is, from a medico-legal perspective, the same as no response at all.

What PHQ-9 Question 9 Actually Asks and What a Positive Response Means

Question 9 of the PHQ-9 reads: over the last two weeks, how often have you been bothered by thoughts that you would be better off dead or of hurting yourself in some way?

The four response options are: 0, not at all; 1, several days; 2, more than half the days; 3, nearly every day.

Any response of 1 or above is a positive response. A score of 1 means the patient has experienced passive thoughts of self-harm or death on at least a few days in the past two weeks. A score of 3 means those thoughts have been present almost every day.

What a positive response to Question 9 means clinically is specific and important to understand accurately. It is a flag for further clinical evaluation. It is not a diagnosis of suicidal intent. It is not a confirmed indication that the patient will act on the thoughts. It is the instrument identifying that those thoughts have been present, which means the clinician needs to know before they sit down with the patient.

The distinction matters because it determines the appropriate clinical response. A score of 1 on Question 9 does not require the same immediate intervention as a score of 3. Both require a documented clinical response before the session begins. The intensity and urgency of that response is calibrated to the score and to the clinical context.

Understanding this baseline is essential before implementing any AI PHQ-9 screening workflow that includes an automated Question 9 alert protocol.

The Clinical Responsibility When Question 9 Is Endorsed

When a patient endorses Question 9 at any level above zero, the outpatient clinic has a clear clinical responsibility. That responsibility has three components.

Component 1 – Further clinical evaluation before the session begins. A positive Question 9 response should trigger a clinical assessment of suicide risk before the patient enters the consultation room. The Columbia Suicide Severity Rating Scale is the standard follow-up tool recommended in clinical guidelines for further evaluation following a positive PHQ-9 Question 9 response. A brief structured risk assessment, conducted by a clinical staff member before the session, determines the appropriate level of clinical response.

Component 2 – Safety planning if clinically indicated. If the clinical evaluation following a positive Question 9 response indicates the patient is at elevated risk, a safety plan should be developed or reviewed before the patient leaves the clinic. For patients with chronic suicidal ideation, safety plan review at each visit is a standard component of outpatient care.

Component 3 – Clinical decision on the session itself. In some cases, a positive Question 9 response with a high clinical risk assessment may indicate that the patient requires a different level of care than an outpatient session can provide. The clinician entering the room with that information can make that determination at the start of the session. A clinician discovering the same information mid-session has no preparation time to make the same decision.

The clinical responsibility is therefore not just to respond, but to respond in time. Pre-visit screening is the only workflow that gives the clinical team the window required to meet that responsibility consistently.

The Legal Responsibility When Question 9 Is Endorsed

The legal responsibility attached to a positive PHQ-9 Question 9 response in an outpatient setting derives from the duty of care that clinicians and clinical organisations owe to patients.

When a screening instrument administered by the clinic identifies a potential suicide risk, the clinic has a documented obligation to respond to that finding. The response must be clinical, it must be timely, and it must be documented. An undocumented clinical response is, from a medico-legal perspective, the same as no response at all. If a patient self-harms following a clinical encounter where a positive Question 9 response was not responded to and not documented, the absence of a documented response creates significant legal exposure for the clinic and the clinician.

The Joint Commission includes suicidal ideation screening and response protocols in its requirements for outpatient behavioural health accreditation. Outpatient clinics seeking or maintaining Joint Commission accreditation must have a documented protocol for responding to positive suicidal ideation flags. Having a protocol is not sufficient. The protocol must be consistently followed and the response must be documented at every applicable visit.

The legal case for consistent Question 9 screening and documented response is therefore not just ethical. It is protective. A clinic with a documented, automated, consistently applied response protocol for Question 9 is in a significantly stronger legal position than a clinic relying on staff memory and paper forms.

Why Some Clinics Are Removing Question 9 and Why That Is Wrong

A STAT News investigation published in August 2025 identified a practice that has emerged in some healthcare organisations: sending patients a PHQ-8 with Question 9 removed, specifically to avoid the legal and clinical obligations that a positive response would create.

The article describes this practice as not only morally indefensible but also unsupported by any clinical evidence and likely born out of stigma regarding mental illness. The authors note that among the core duties of clinicians, perhaps the most fundamental is to promote the health and well-being of patients. Omitting the question that screens for thoughts of self-harm in order to avoid the responsibility that a positive response creates is a direct failure of that duty.

The liability argument used to justify removing Question 9 is also factually incorrect. A clinic that screens for suicidal ideation, receives a positive response, and responds to it with a documented clinical protocol is not more legally exposed than one that does not screen. It is less exposed. The legal risk is not in finding the flag. It is in missing it.

For outpatient clinics considering any modification to their PHQ-9 administration, removing Question 9 is not a risk management strategy. It is a clinical and ethical failure with real legal consequences.

What the Research Says

Four findings from peer-reviewed research and clinical investigation are directly relevant to PHQ-9 Question 9 clinical and legal responsibilities in outpatient settings.

Finding 1 – Omitting Question 9 is unsupported by evidence. The STAT News investigation from August 2025 confirmed that the practice of omitting Question 9 from PHQ-9 administration is not supported by clinical evidence, is not endorsed by any clinical guideline, and is directly contrary to the duty of care that outpatient clinics owe to their patients. The article noted that it is impossible to quantify how many organisations have adopted this practice, which makes it a systemic risk rather than an isolated one.

Finding 2 – PHQ-9 Item 9 is a flag, not a definitive risk assessment. A validation study published in ScienceDirect found that PHQ-9 Item 9 has limited utility as a standalone suicide risk assessment tool and shows limited reliability in certain demographic and clinical subgroups. This finding does not argue against using Question 9. It argues for using it as the flag it is designed to be and following it with a structured clinical risk assessment rather than treating a positive score as a definitive clinical conclusion.

Finding 3 – Machine learning using PHQ-9 achieves 94.3% accuracy for suicidal ideation screening. A study published in NCBI PMC found that machine learning algorithms applied to PHQ-9 responses achieved 94.3% accuracy in screening for suicidal ideation, with positive and negative predictive values of 84.95% and 95.54% respectively. The study confirmed that the PHQ-9 in the primary care field is reliably accurate in screening individuals with suicidal ideation when used as designed.

Finding 4 – AAFP supports PHQ-9 Item 9 as a component of clinical screening. The American Academy of Family Physicians explicitly supports the use of PHQ-9 Item 9 as a component of screening during a clinical interview, noting that most individuals who die by suicide have visited mental health services providers within one year before death. Outpatient visits are clinical opportunities to identify and respond to suicidal ideation. PHQ-9 Question 9 is the tool that makes those opportunities consistent rather than dependent on whether the clinician remembers to ask.

The Alert Protocol That Works in an Outpatient Setting

A clinical alert protocol for PHQ-9 Question 9 in an outpatient setting requires three elements to function reliably.

Element 1 – The alert reaches the right person. The alert must go to a designated clinical staff member, not a general inbox or a front desk coordinator. In an outpatient mental health or psychiatry clinic, the designated recipient is typically a nurse, a clinical coordinator, or the clinician’s direct support staff. In a smaller solo practice, the alert may go directly to the clinician.

Element 2 – The alert arrives before the patient enters the room. An alert that fires when the patient is already in the consultation room serves no clinical purpose. The entire value of the Question 9 alert is that it gives the clinical team time to respond before the session begins. This requires pre-visit screening, not in-room administration.

Element 3 – The protocol specifies what happens next. The alert itself is not the response. The protocol must specify what the designated staff member does when the alert fires. At minimum, the protocol should include a brief clinical check-in with the patient before they enter the room, documentation of the check-in, and notification to the clinician before they begin the session.

Without all three elements, the alert exists but the protocol does not function. This applies equally to psychiatry clinics and outpatient behavioural health centres.

How AI PHQ-9 Screening Changes the Response Timeline

The response timeline is the single most important variable in the clinical and legal management of PHQ-9 Question 9 in an outpatient setting. Pre-visit AI screening changes that timeline in a way that no in-room administration workflow can replicate.

With in-room paper administration, the earliest the clinical team can know about a positive Question 9 response is when the form is collected and scored during the session. The clinician may already be in the room. The preparation window is zero.

With pre-visit voice-guided AI PHQ-9 screening, the patient completes the questionnaire before they arrive at the clinic. When Question 9 is endorsed, MedLaunch sends an immediate alert to the designated clinical staff member. The patient has not yet arrived. The clinical team has time to prepare a response, conduct a brief structured risk assessment, and brief the clinician before the session begins.

The difference is not marginal. It is the difference between discovering a clinical flag before the patient is in the room and discovering it after. That preparation window is where the clinical response happens. Without pre-visit screening, it does not exist.

For a deeper look at how pre-visit AI PHQ-9 administration compares to clinician-administered screening on accuracy, see AI PHQ-9 Accuracy vs Clinician Administered: What the Research Says in 2026.

Documentation Requirements When Question 9 Is Flagged

When PHQ-9 Question 9 is endorsed at any level above zero, the clinical note for that visit must contain six elements to satisfy both clinical best practice and medico-legal requirements.

1 – The instrument name and total score. The note must document that the PHQ-9 was administered and record the total score.

2 – The specific Question 9 response. The note must document the patient’s specific response to Question 9, for example “Patient scored 2 on PHQ-9 Question 9, indicating thoughts of self-harm more than half the days in the past two weeks.”

3 – The clinical assessment following the flag. The note must document what clinical evaluation was conducted in response to the positive Question 9, including the tool used such as the Columbia Suicide Severity Rating Scale and the outcome of that assessment.

4 – The clinical action taken. The note must document what the clinician did in response to the assessment. This may include safety planning, medication adjustment, referral for higher level of care, or scheduled follow-up within a specific interval.

5 – The safety plan if applicable. If a safety plan was developed or reviewed, the note must document that it was completed and that the patient participated in its development.

6 – The follow-up interval. The note must document when the next clinical contact is scheduled and what the purpose of that contact is.

An incomplete note creates an incomplete clinical record and incomplete legal protection. For outpatient clinics using AI PHQ-9 screening, the instrument name, total score, and Question 9 response are captured automatically in the structured report. The clinician documents elements 3 through 6. For a detailed overview of how PHQ-9 implementation supports consistent documentation, see PHQ-9 Implementation in a Busy Mental Health Clinic.

What This Means for Your Clinic in 2026

PHQ-9 Question 9 creates the most significant clinical and legal responsibility in routine outpatient depression screening. The responsibility is not whether the clinic responds. It is whether the clinic responds in time, consistently, with a documented protocol that applies at every eligible visit.

A clinic using in-room paper PHQ-9 administration cannot consistently meet that timing requirement because the flag is not known until the form is collected and scored during the session. A clinic using pre-visit AI PHQ-9 screening receives the Question 9 alert before the patient arrives and has the preparation window the clinical response requires.

The clinics that remove Question 9 to avoid the responsibility it creates are trading a manageable clinical and operational challenge for a significant ethical and legal failure. The evidence does not support that trade.

MedLaunch AI Powered PHQ-9 Screening includes an immediate Question 9 alert to designated clinical staff as a core feature of every deployment. It cannot be disabled. It applies at every visit where the PHQ-9 is administered. That is not a product decision. It is a clinical one.

Frequently Asked Questions

What does a positive PHQ-9 Question 9 response mean clinically?

A positive response to PHQ-9 Question 9, any response above zero, indicates the patient has experienced thoughts of self-harm or death in the past two weeks. It is a clinical flag for further evaluation, not a diagnosis of suicidal intent. A score of 1 indicates passive thoughts on several days. A score of 3 indicates those thoughts have been present nearly every day. Both require a documented clinical response before the consultation begins, calibrated to the score and the clinical context.

What should a clinic do immediately when Question 9 is endorsed?

When PHQ-9 Question 9 is endorsed, the designated clinical staff member should conduct a brief structured risk assessment before the patient enters the consultation room. The Columbia Suicide Severity Rating Scale is the standard follow-up tool for this assessment. The outcome of the assessment and the clinical action taken must be documented in the patient record for that visit. The clinician should be briefed before the session begins.

Is it legal to remove Question 9 from the PHQ-9?

There is no law that specifically prohibits administering the PHQ-8 in place of the PHQ-9. However, removing Question 9 to avoid the clinical and legal obligations a positive response creates is directly contrary to the duty of care outpatient clinics owe to their patients. As reported by STAT News in August 2025, this practice is clinically and ethically indefensible and unsupported by any evidence. A clinic that screens with PHQ-8 and misses a suicidal patient is in a significantly worse legal position than one that screens with PHQ-9, receives a positive Question 9 response, and documents a clinical response.

What documentation is required when PHQ-9 Question 9 is flagged?

When Question 9 is endorsed, the clinical note must contain the instrument name and total score, the specific Question 9 response, the clinical assessment conducted in response such as a Columbia Suicide Severity Rating Scale evaluation, the clinical action taken, any safety plan developed or reviewed, and the follow-up interval. An incomplete note creates incomplete legal protection regardless of what clinical actions were taken in the room.

How does AI PHQ-9 screening handle a positive Question 9 response?

MedLaunch AI Powered PHQ-9 Screening sends an immediate alert to the designated clinical staff member when a patient endorses Question 9 during pre-visit screening. Because the screening is completed before the patient arrives at the clinic, the alert reaches clinical staff before the patient enters the building. This gives the team time to conduct a brief risk assessment and brief the clinician before the session begins. The alert is a core feature of every MedLaunch deployment and cannot be disabled.

What is the difference between PHQ-9 and PHQ-8 regarding suicidal ideation?

The PHQ-8 is identical to the PHQ-9 with Question 9 removed. It was originally developed for research contexts where screening for suicidal ideation was not clinically appropriate, such as population surveys. It was never designed for routine clinical use as a replacement for the PHQ-9. Using the PHQ-8 in a clinical outpatient setting removes the only item that screens for thoughts of self-harm, which is both clinically and ethically indefensible as confirmed by STAT News in August 2025.

Conclusion

PHQ-9 Question 9 is the most clinically significant item on the questionnaire. The responsibility it creates for outpatient clinics is not ambiguous. A non-zero response requires a documented clinical response before the patient reaches the clinician. The timing is the responsibility. Not just whether a response happens, but when.

A pre-visit screening workflow that delivers the Question 9 flag to clinical staff before the patient arrives at the clinic is the only workflow that consistently meets that timing requirement. In-room paper administration cannot provide that window. The flag is discovered when the form is collected, which is too late for clinical preparation.

The practice of removing Question 9 to avoid the obligation it creates is not a risk management strategy. It is a clinical failure. The legal exposure created by missing a suicidal patient is significantly greater than the operational challenge of responding to a positive Question 9 flag with a documented clinical protocol.